Literature DB >> 3156696

Diabetes mellitus in Huntington disease.

L A Farrer.   

Abstract

There have been conflicting reports that individuals with Huntington disease (HD) are prone to abnormalities of carbohydrate metabolism. In this study information about the incidence and control of diabetes mellitus in 620 probands (278 living, 332 deceased) with HD and in their first and second degree relatives was obtained by questionnaire method from participants of the National HD Research Roster. Among the probands, 65 individuals (10.5%) were identified by the informant or verified by examination of Roster family records as diabetic. The prevalence of diabetes, particularly among those les than 50 years of age, is significantly greater than corresponding figures among the general U.S. Caucasian population (Scott 1977, Krolewski & Warram 1985). Incidence rates were not calculated because of ascertainment and other biases in the data. Results from the analysis of family data indicate that HD affected relatives of an HD proband with diabetes are 7 times as likely to have diabetes over the proband's non-HD relatives. A non-diabetic HD proband is equally likely to have an HD or non-HD relative with diabetes.

Entities:  

Mesh:

Year:  1985        PMID: 3156696     DOI: 10.1111/j.1399-0004.1985.tb00185.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  50 in total

Review 1.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 3.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

4.  Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.

Authors:  Trent Nguyen; Aaron Hamby; Stephen M Massa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

5.  HAP1 helps to regulate actin-based transport of insulin-containing granules in pancreatic β cells.

Authors:  Zhiyong Wang; Ting Peng; Hongnian Wu; Jun He; He Li
Journal:  Histochem Cell Biol       Date:  2015-03-06       Impact factor: 4.304

6.  The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.

Authors:  Mark Minie; Stuart Bowers; Peter Tarczy-Hornoch; Edward Roberts; Rose A James; Neil Rambo; Sherrilynne Fuller
Journal:  J Med Libr Assoc       Date:  2006-07

Review 7.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

Review 8.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

9.  Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1.

Authors:  Jing-Ying Pan; Shijin Yuan; Tao Yu; Cong-Lin Su; Xiao-Long Liu; Jun He; He Li
Journal:  J Biol Chem       Date:  2016-09-13       Impact factor: 5.157

Review 10.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.